Literature DB >> 7803274

The differences in quantities of alpha 2- and alpha 1-globin gene variants in heterozygotes.

T P Molchanova1, D D Pobedimskaya, T H Huisman.   

Abstract

We have identified through sequencing of amplified DNA the mutations in the alpha 2- and alpha 1-globin genes in 63 individuals with a heterozygosity for an alpha chain abnormal haemoglobin (Hb). Moreover, we developed a reverse transcription/polymerase chain reaction (RT/PCR) based procedure for the determination of the alpha 2- and alpha 1-mRNA ratio in normal individuals. The numbers of alpha 2 and alpha 1 variants were nearly the same. The average percentage of the abnormal Hb in heterozygotes with alpha 2 mutations (23.5%) was slightly higher than that in heterozygotes with alpha 1 mutations (19.7%) (stable Hbs only). These percentages correspond to a ratio of alpha 2 to alpha 1 of 1.19 to 1 at the protein level. Variations in the number of active alpha-globin genes and in the stability of the variants (greatly) affected the percentages of the abnormal protein. The average ratio between the alpha 2- and alpha 1-mRNAs in 12 normal individuals was 2.6-2.75 to 1, about as expected from published data, and 2.0 to 1 for two persons with an alpha-thalassaemia-2 (alpha-thal-2) (-3.7 kb) heterozygosity. The high relative mRNA (alpha 2) level which is about twice the relative level of the alpha 2 protein suggests a less efficient translation of the alpha 2-mRNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803274     DOI: 10.1111/j.1365-2141.1994.tb05022.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Hb Q-India: an uncommon variant diagnosed in three Punjabi patients with diabetes is identified by a novel DNA analysis test.

Authors:  R Abraham; M Thomas; R Britt; C Fisher; J Old
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Coinheritance of Sicilian (δβ)0-Thalassemia and Two Rare Hemoglobin Variants: A Complex Case of Hemoglobinopathy.

Authors:  Hajar Eftekhari; Maryam Pilehchian Langroudi; Ali Banihashemi; Mandana Azizi; Reza Youssefi Kamangar; Haleh Akhavan-Niaki
Journal:  Indian J Clin Biochem       Date:  2017-07-05

3.  Molecular basis and hematological features of hemoglobin variants in Southern Thailand.

Authors:  Vannarat Saechan; Chawadee Nopparatana; Chamnong Nopparatana; Suthat Fucharoen
Journal:  Int J Hematol       Date:  2010-09-14       Impact factor: 2.490

4.  Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.

Authors:  Giulia Pavani; Anna Fabiano; Marine Laurent; Fatima Amor; Erika Cantelli; Anne Chalumeau; Giulia Maule; Alexandra Tachtsidi; Jean-Paul Concordet; Anna Cereseto; Fulvio Mavilio; Giuliana Ferrari; Annarita Miccio; Mario Amendola
Journal:  Blood Adv       Date:  2021-03-09

5.  Hb J- Meerut [alpha 120 (H3) Ala ->Glu (alpha1)] in a Turkish male.

Authors:  Gunçag Dinçol; Serkan Güvenç; Dedrey Elam; Abdullah Kutlar; Ferdane Kutlar
Journal:  Int J Med Sci       Date:  2006-02-02       Impact factor: 3.738

6.  Alpha-globin gene mutation spectrum in patients with microcytic hypochromic anemia from Mazandaran Province, Iran.

Authors:  Seyed Mohammad Bagher Hashemi-Soteh; Hossein Karami; Seyed Saeid Mousavi; Touraj Farazmandfar; Ahmad Tamadoni
Journal:  J Clin Lab Anal       Date:  2019-09-02       Impact factor: 3.124

7.  Mutations in the paralogous human alpha-globin genes yielding identical hemoglobin variants.

Authors:  Kamran Moradkhani; Claude Préhu; John Old; Shirley Henderson; Vera Balamitsa; Hong-Yuan Luo; Man-Chiu Poon; David H K Chui; Henri Wajcman; George P Patrinos
Journal:  Ann Hematol       Date:  2008-10-16       Impact factor: 3.673

8.  Haemoglobin switching modulator SNPs rs5006884 is associated with increased HbA2 in β-thalassaemia carriers.

Authors:  Cyril Cyrus; Chittibabu Vatte; Shahanas Chathoth; Abdul Azeez Sayed; J Francis Borgio; Mohammed Abdullah Alrubaish; Rawan Alfalah; Jana Alsaikhan; Amein K Al Ali
Journal:  Arch Med Sci       Date:  2019-07-18       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.